The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0

…, A Alavi, HR Balon, SEM Clarke… - Journal of Nuclear …, 2012 - Soc Nuclear Med
THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

…, L Livieratos, G Gnanasegaran, SEM Clarke… - European journal of …, 2010 - Springer
Purpose The purpose of this study was to investigate the additional value of single photon
emission computed tomography/computed tomography (SPECT/CT) over whole-body planar …

Procedure guideline for therapy of thyroid disease with 131Iodine

…, DR Brill, DV Becker, SEM Clarke… - Journal of Nuclear …, 2002 - Soc Nuclear Med
The purpose of this guideline is to assist nuclear medicine practitioners in evaluating patients
for therapy with 131I (sodium iodide) for benign or malignant conditions of the thyroid gland…

Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a …

…, H Mehanna, H Mohan, SEM Clarke… - Journal of medical …, 2012 - jmg.bmj.com
Five single nucleotide polymorphisms (SNPs) associated with thyroid cancer (TC) risk have
been reported: rs2910164 (5q24); rs6983267 (8q24); rs965513 and rs1867277 (9q22); and …

[HTML][HTML] Synthesis and biological evaluation of [18F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide …

…, MJ O'Doherty, PK Marsden, SEM Clarke… - European journal of …, 2010 - Springer
Synthesis and biological evaluation of [18F]tetrafluoroborate: a PET imaging agent for thyroid
disease and reporter gene imaging of the sodium/iodide symporter | European Journal of …

[PDF][PDF] Pentavalent [99mTc] DMSA,[131I] MIBG, and [99mTc] MDP-an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid

SEM Clarke, CR Lazarus, P Wraight… - Journal of Nuclear …, 1988 - Soc Nuclear Med
… For reprints contact: Susan EM Clarke, MD, Dept. of Nuclear … Clarke SEM, Lazarus CR,
Fogelman I, et al. Technetium-99m(V>DMSA in the imaging of medullary thy roid carcinoma. J …

[BOOK][B] An atlas of clinical nuclear medicine

I Fogelman, MN Maisey, SEM Clarke - 1994 - books.google.com
This atlas, the first edition of which won the 1989 Glaxo Prize for Medical Writing, has now
been brought up to date to cover new techniques in the field. Every major body system is …

[PDF][PDF] The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid

PJ Blower, J Singh, SEM Clarke - Journal of Nuclear Medicine, 1991 - Soc Nuclear Med
Nuclear Medicine Dept, Kent and Canterbury Hospital, Canterbury, United Kingdom; Biological
Laboratory, The University, Canterbury, UnitedKingdom; and Nuclear Medicine Dept, …

[PDF][PDF] Technetium-99m-DMSA studies in pediatric urinary tract infection

SEM Clarke, JM Smellie, N Prescod… - Journal of Nuclear …, 1996 - Soc Nuclear Med
MATERIALS AND METHODS We studied children with symptomatic, bacteriologically proven
UTI referred to the nuclear medicine department at Guy's Hospital between 1985 and 1990 …

Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene

…, T Kantemiroff, C Harmer, SEM Clarke… - …, 2004 - academic.oup.com
Benign thyroid disorders are strong risk factors for non-medullary thyroid cancer (NMTC).
Germline variation in Tg (thyroglobulin) and TSHR (thyroid stimulating hormone receptor) …